Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: a multicenter real-world study in the northwest of China
- DOI
- 10.1186/s12885-023-10568-0
- Published
- 2023-01-30
- Container
- BMC Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-023-10568-0,
title = {Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: a multicenter real-world study in the northwest of China},
author = {Jiao Yang and Bing Zhao and Xiaoling Ling and Donghui Li and Jiuda Zhao and Yonggang Lv and Guangxi Wang and Xinlan Liu and Nanlin Li and Jin Yang},
year = {2023},
journal = {BMC Cancer},
doi = {10.1186/s12885-023-10568-0},
url = {https://doi.org/10.1186/s12885-023-10568-0}
}RIS
TY - JOUR TI - Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: a multicenter real-world study in the northwest of China AU - Jiao Yang AU - Bing Zhao AU - Xiaoling Ling AU - Donghui Li AU - Jiuda Zhao AU - Yonggang Lv AU - Guangxi Wang AU - Xinlan Liu AU - Nanlin Li AU - Jin Yang PY - 2023 JO - BMC Cancer DO - 10.1186/s12885-023-10568-0 UR - https://doi.org/10.1186/s12885-023-10568-0 ER -
APA
Yang, J., Zhao, B., Ling, X., Li, D., Zhao, J., Lv, Y., Wang, G., Liu, X., Li, N., & Yang, J. (2023). Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: a multicenter real-world study in the northwest of China. BMC Cancer. https://doi.org/10.1186/s12885-023-10568-0
Source records
- crossref · retrieved 2026-09-27T08:37:54.530Z